window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 19, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

gene delivery

  • Advanced Therapies,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain

    VectorBuilder and Lir Therapeutics partner on AI-guided AAV capsid engineering

    VectorBuilder and Lir Therapeutics have entered a collaboration to optimise [...]

    August 19, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    N4 Pharma and SRI demonstrate targeted Nuvec delivery to lung cancer cells

    N4 Pharma has reported new data from its collaboration with [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    SpliceBio secures $135 Million series B to advance dual-AAV therapy for Stargardt Disease

    Funding will support clinical development of SB-007 and expand pipeline [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Prescient integrates Uptake and Dolon to create 550-strong pharma consultancy
    Categories: Biotech & Pharma Business
  • Tris Pharma partners with Calm Health and ADHD Central to support patients
    Categories: Digital & Data, Pharmaceuticals and therapeutics, Therapeutic Areas
  • US FDA inspects Aurisco site for generic oligonucleotide manufacturing
    Categories: Drug Discovery & Development, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top